Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Taxanes are chemotherapy drugs used in cancer treatment.
• Reactive oxygen species (ROS) play a role in cancer cell death and drug resistance.
• Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer.

Purpose of the Study:

• To investigate the relationship between taxane-induced ROS production and cytotoxic effects in CRPC cells.
• To compare the efficacy of docetaxel and cabazitaxel in CRPC.
• To elucidate the mechanism of cabazitaxel's action involving ROS.

Main Methods:

• Human CRPC cell lines were treated with docetaxel and cabazitaxel in vitro.
• Cell viability was assessed at increasing drug concentrations.
• ROS production was measured using FACS analysis.
• The effect of N-acetylcysteine (NAC), an antioxidant, on cabazitaxel-induced cell death was evaluated.
• The expression of Sestrin-3 (SESN3) was analyzed.

Main Results:

• Cabazitaxel exhibited significantly higher cytotoxic efficacy than docetaxel in CRPC cells.
• Cabazitaxel treatment led to elevated ROS production compared to docetaxel.
• The antioxidant NAC reduced the cytotoxic effect of cabazitaxel.
• Cabazitaxel, but not docetaxel, inhibited ROS elimination by SESN3.

Conclusions:

• Cabazitaxel's enhanced efficacy in CRPC is associated with increased ROS production.
• Inhibition of the antioxidant enzyme SESN3 by cabazitaxel contributes to its cytotoxic effect.
• These findings suggest a potential therapeutic advantage of cabazitaxel in CRPC through ROS modulation.